Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
14
Number of overlapping holdings
28.0%
% of FTXH's 51 holdings also in MEDX
46.7%
% of MEDX's 30 holdings also in FTXH
Overlap by Weight
Sector Drift (FTXH minus MEDX)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FTXH |
Weight in MEDX |
Overlap | |
|---|---|---|---|---|
 |
ABBVIE INC | 6.8% | 7.3% | 6.8% |
|
MERCK & CO. INC. | 7.6% | 5.2% | 5.2% |
|
BRISTOL-MYERS SQUIBB CO | 6.5% | 4.7% | 4.7% |
|
JOHNSON & JOHNSON | 6.9% | 4.5% | 4.5% |
|
PFIZER INC | 7.8% | 4.3% | 4.3% |
Position Highlights (Non-Overlapping Exposures)
FTXH Overweight Relative to MEDX
|
UNITED THERAPEUTICS CORP | 3.9% |
|
VERTEX PHARMACEUTICALS INC | 3.7% |
|
PFIZER INC | 3.5% |
|
GILEAD SCIENCES INC | 3.4% |
|
CARDINAL HEALTH INC | 3.3% |
|
ZOETIS INC | 3.2% |
|
VIATRIS, INC. | 3.1% |
 |
JAZZ PHARMACEUTICALS PLC | 3.0% |
|
ORGANON & CO. | 3.0% |
|
MERCK & CO. INC. | 2.4% |
FTXH Underweight Relative to MEDX
|
ELI LILLY & CO | -11.3% |
 |
NOVARTIS AG-ADR | -5.8% |
 |
ASTRAZENECA PLC-SPONS ADR | -5.7% |
|
GLAXOSMITHKLINE PLC-SPON ADR | -3.0% |
|
CRISPR THERAPEUTICS AG | -2.9% |
|
ALNYLAM PHARMACEUTICALS INC | -2.6% |
|
IONIS PHARMACEUTICALS, INC. | -2.4% |
|
ALKERMES PLC | -2.3% |
|
INTELLIA THERAPEUTICS, INC. | -2.1% |
|
AMGEN INC | -2.0% |